In the biotech industry, few things disrupt operations and damage reputations like receiving an FDA Form 483. These inspectional observations highlight areas where a company
As regulatory agencies embrace digital transformation, remote FDA inspections have become a standard practice, especially in biotech and pharmaceutical environments. These virtual audits offer flexibility
In the biotech industry, an FDA inspection can be a defining moment. Whether you’re a startup or a scaling enterprise, your team’s preparedness directly impacts
When the FDA arrives for an inspection, biotech companies must be ready to demonstrate compliance, transparency, and control. Success hinges not only on systems and
In the biotech industry, FDA inspection readiness isn’t just about having SOPs in place, it’s about proving that your systems, teams, and processes consistently meet
In the biotech and pharmaceutical sectors, laboratory systems like LIMS (Laboratory Information Management Systems), ELN (Electronic Lab Notebooks), and CDS (Chromatography Data Systems) are essential
For biotech startups, securing FDA approval is a major milestone but passing an FDA inspection is often the first real test of operational maturity. With
FDA inspections of clinical trials are designed to ensure that studies are conducted ethically, safely, and in accordance with Good Clinical Practice (GCP). For biotech